BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6537 related articles for article (PubMed ID: 2851058)

  • 1. Regulation of Schwann cell nerve growth factor receptor by cyclic adenosine 3',5'-monophosphate.
    Mokuno K; Sobue G; Reddy UR; Wurzer J; Kreider B; Hotta H; Baron P; Ross AH; Pleasure D
    J Neurosci Res; 1988; 21(2-4):465-72. PubMed ID: 2851058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Schwann cell phenotype by TGF-beta 1: inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor.
    Mews M; Meyer M
    Glia; 1993 Jul; 8(3):208-17. PubMed ID: 7693590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of growth-associated protein-43 kD in Schwann cells is regulated by axon-Schwann cell interactions and cAMP.
    Scherer SS; Xu YT; Roling D; Wrabetz L; Feltri ML; Kamholz J
    J Neurosci Res; 1994 Aug; 38(5):575-89. PubMed ID: 7815473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells.
    Sonnenfeld KH; Bernd P; Sobue G; Lebwohl M; Rubenstein AE
    Cancer Res; 1986 Mar; 46(3):1446-52. PubMed ID: 3002618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental lead neuropathy: inorganic lead inhibits proliferation but not differentiation of Schwann cells.
    Sobue G; Pleasure D
    Ann Neurol; 1985 May; 17(5):462-8. PubMed ID: 2988413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of Schwann cells in peripheral nerve degeneration and regeneration--NGF-NGF receptor system].
    Sobue G
    Rinsho Shinkeigaku; 1990 Dec; 30(12):1358-60. PubMed ID: 1966016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic fibroblast growth factor prevents cAMP-induced apoptosis in cultured Schwann cells.
    Shaw R; Cianchetti R; Pleasure D; Kreider B
    J Neurosci Res; 1997 Feb; 47(4):400-4. PubMed ID: 9057133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of fast axonal transport in vivo leads to alterations in Schwann cell gene expression.
    Wu W; Toma JG; Chan H; Smith R; Miller FD
    Dev Biol; 1994 Jun; 163(2):423-39. PubMed ID: 7515362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
    Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
    J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and low-affinity nerve growth factor receptor (LNGFR) mRNA levels in cultured rat Schwann cells; differential time- and dose-dependent regulation by cAMP.
    Yamamoto M; Sobue G; Li M; Arakawa Y; Mitsuma T; Kimata K
    Neurosci Lett; 1993 Apr; 152(1-2):37-40. PubMed ID: 8390628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axons modulate the expression of transforming growth factor-betas in Schwann cells.
    Scherer SS; Kamholz J; Jakowlew SB
    Glia; 1993 Aug; 8(4):265-76. PubMed ID: 8406683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of parathyroid hormone-related peptide following peripheral nerve injury: role as a modulator of Schwann cell phenotype.
    Macica CM; Liang G; Lankford KL; Broadus AE
    Glia; 2006 Apr; 53(6):637-48. PubMed ID: 16470617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP.
    Schumacher M; Jung-Testas I; Robel P; Baulieu EE
    Glia; 1993 Aug; 8(4):232-40. PubMed ID: 8406680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cAMP on differentiation of cultured Schwann cells: progression from an early phenotype (04+) to a myelin phenotype (P0+, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition.
    Morgan L; Jessen KR; Mirsky R
    J Cell Biol; 1991 Feb; 112(3):457-67. PubMed ID: 1704008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PC12 cells regulate inducible cyclic AMP (cAMP) element repressor expression to differentially control cAMP response element-dependent transcription in response to nerve growth factor and cAMP.
    Chang JH; Vuppalanchi D; van Niekerk E; Trepel JB; Schanen NC; Twiss JL
    J Neurochem; 2006 Dec; 99(6):1517-30. PubMed ID: 17059558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo.
    Stewart HJ; Rougon G; Dong Z; Dean C; Jessen KR; Mirsky R
    Glia; 1995 Dec; 15(4):419-36. PubMed ID: 8926036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forskolin increases neuregulin receptors in human Schwann cells without increasing receptor mRNA.
    Fregien NL; White LA; Bunge MB; Wood PM
    Glia; 2005 Jan; 49(1):24-35. PubMed ID: 15390106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated intracellular levels of cAMP induce olfactory ensheathing cells to express GAL-C and GFAP but not MBP.
    Doucette R; Devon R
    Glia; 1995 Feb; 13(2):130-40. PubMed ID: 7544324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate.
    Sobue G; Pleasure D
    Science; 1984 Apr; 224(4644):72-4. PubMed ID: 6322307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of steroidogenic acute regulatory protein (StAR) gene expression by cyclic AMP in cultured Schwann cells.
    Benmessahel Y; Troadec JD; Cadepond F; Guennoun R; Hales DB; Schumacher M; Groyer G
    Glia; 2004 Feb; 45(3):213-28. PubMed ID: 14730695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 327.